Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Neurones S.A. Earnings Release 2014

Nov 12, 2014

1548_iss_2014-11-12_6100ccbc-bde4-4ed8-b97a-f819311a8bfe.pdf

Earnings Release

Open in viewer

Opens in your device viewer

PRESS INFORMATION Heading: 3rd quarter 2014 revenues Nanterre, November 12, 2014

Organic growth up 4.3% in the first nine months of 2014

(not audited, in millions of
euros)
2014 2013 Growth
rd quarter revenues
3
83.7 81.5 +
2.7%
Total as at the end-September 260.8 250.0 +
4.3%

Achievements

NEURONES posted a wholly organic 4.3% rise in growth over the first nine months of the year.

Operating profit (*) in the 3rd quarter amounted to 10.6% and totaled 9.6% of revenues over the first three quarters of the year compared to 9.3% at end-September 2013.

Net cash and cash equivalents (no financial debt) increased from €90 million to €109 million compared to September 30, 2013.

(*) not audited and after inclusion of 0.2% of expenses related to free shares and stock options.

Outlook

For the last three months of 2014, NEURONES forecasts growth on a par with that of the 3rd quarter and, for 2014 as a whole, the Group is expecting a higher operating profit that its initial forecast of €32.4 million.

About NEURONES

With 4,000 experts, the NEURONES group is specialized in Consulting (Management and Organization) and IT Services (Infrastructures and Applications). It supports its clients in their change-management projects and in the upgrading and outsourcing of their Information Systems.

NYSE Euronext: Compartment B – ISIN code: FR0004050250 – NYSE symbol: NRO www.neurones.net

Press Relations: Florence Gillier Communication Frédérique Guillo Tel.: +33 (0)1 41 18 85 55 [email protected]

NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 [email protected]

Investor relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 [email protected]